Alixia is a medical research company that engages in developing new modalities to treat cancer, aging, and inflammation.
Alixia has raised $1.8M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Alixia's investors include Y Combinator, Gaingels, ZAKA VC, Eight Capital.
Alixia is headquartered in San Francisco, United States.
Alixia is a medical research company that engages in developing new modalities to treat cancer, aging, and inflammation.
Alixia is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Alixia — Funding & Investors." VCBacked, October 1, 2024, https://www.vcbacked.co/company/alixia. Accessed August 15, 2026.
VCBacked. (2024). Alixia — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/alixia
{{cite web |title=Alixia — Funding & Investors |url=https://www.vcbacked.co/company/alixia |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated